The natural killer–activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|54|6|1515-1521

ISSN： 0041-1132

Source： TRANSFUSION, Vol.54, Iss.6, 2014-06, pp. : 1515-1521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti‐CD3 antibody

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1832-1842

John Wiley & Sons Inc

Access to resources Recommend Favorite

Type I Interferon Plays Opposing Roles in Cytotoxicity and Interferon-γ Production by Natural Killer and CD8+ T Cells after Influenza A Virus Infection in Mice

By  

Journal of Innate Immunity, Vol. 6, Iss. 4, 2014-01 ,pp. : 456-466

Karger

Access to resources Recommend Favorite

CD1d-Restricted Natural Killer T Cells: Roles in Tumor Immunosurveillance and Tolerance

By  

Transfusion Medicine and Hemotherapy, Vol. 33, Iss. 1, 2006-01 ,pp. : 18-36

Karger

Access to resources Recommend Favorite

Evidence for eomesodermin‐expressing innate‐like CD8+ KIR/NKG2A+ T cells in human adults and cord blood samples

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 7, 2015-07 ,pp. : 1926-1933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1–3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP‐recipient natural killer cells

By  

IMMUNOLOGY, Vol. 146, Iss. 1, 2015-09 ,pp. : 70-80

John Wiley & Sons Inc

Access to resources Recommend Favorite